Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome

被引:58
作者
Dove-Edwin, Isis
De Jong, Andrea E.
Adams, Joanna
Mesher, David
Lipton, Lara
Sasieni, Peter
Vasen, Hans F. A.
Thomas, Huw J. W.
机构
[1] St Marks Hosp, Family Canc Grp, Canc Res UK, Colorectal Canc Unit, Harrow HA1 3UJ, Middx, England
[2] Leiden Univ, Med Ctr, Dept Gastroenterol, Netherlands Fdn Detect Hereditary Tumours, Leiden, Netherlands
[3] Wolfson Inst Prevent Med, United Kingdom Ctr Epidemiol Math & Stat, London, England
关键词
D O I
10.1053/j.gastro.2006.03.018
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Lynch syndrome is an autosomal dominant predisposition to colorectal cancer caused by mutations in DNA mismatch repair genes; colorectal cancer risk is high. Few studies have addressed colorectal cancer risk in individuals from dominant families without mismatch repair deficiency. We sought to establish whether these individuals are also at increased risk by examining the incidence of advanced neoplasia during surveillance. Methods: In this prospective cohort study, BAT26 testing of tumors was carried out at 2 tertiary centers on 125 individuals from 97 families (with a dominant colorectal cancer history) to classify families as Lynch syndrome (microsatellite unstable) or non-Lynch syndrome (microsatellite stable). Colonoscopy results in 288 at-risk family members were compared. Results: Twenty-nine families were classified as Lynch syndrome and 68 as non-Lynch syndrome. Seven hundred seventy-six colonoscopies were undertaken. High-risk adenomas occurred in 7 of 91 (7.7%) Lynch syndrome individuals and 15 of 197 (7.6%) non-Lynch syndrome individuals, adjusted relative risk 1.15 (95% CI: 0.6-2.3). Cancer was observed only in Lynch syndrome individuals (4/91; 4.4%), Fisher exact test, P =.010. Multiple adenomas were only seen in non-Lynch syndrome individuals (13/197; 6.6%), Fisher exact text, P =.06. Conclusions: Individuals with an autosomal dominant family history of colorectal cancer with and without evidence of Lynch syndrome are at equal risk of high-risk adenomas during surveillance, but colorectal cancer was only seen in Lynch syndrome. Therefore non-Lynch syndrome individuals do require colonoscopic surveillance, but the interval could be lengthened because risk of (interval) cancer is low. Lynch syndrome individuals require short surveillance intervals as is the recommended practice.
引用
收藏
页码:1995 / 2000
页数:6
相关论文
共 19 条
[1]   Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease [J].
Aaltonen, LA ;
Salovaara, R ;
Kristo, P ;
Canzian, F ;
Hemminki, A ;
Peltomäki, P ;
Chadwick, RB ;
Kääriäinen, H ;
Eskelinen, M ;
Järvinen, H ;
Mecklin, JP ;
de la Chapelle, A ;
Percesepe, A ;
Ahtola, H ;
Härkönen, N ;
Julkunen, R ;
Kangas, E ;
Ojala, S ;
Tulikoura, J ;
ValKamo, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (21) :1481-1487
[2]   Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer [J].
de Jong, AE ;
van Puijenbroek, M ;
Hendriks, Y ;
Tops, C ;
Wijnen, J ;
Ausems, MGEM ;
Meijers-Heijboer, H ;
Wagner, A ;
van Os, TAM ;
Bröcker-Vriends, AHJT ;
Vasen, HFA ;
Morreau, H .
CLINICAL CANCER RESEARCH, 2004, 10 (03) :972-980
[3]   Testing tumors for microsatellite instability [J].
de la Chapelle, A .
EUROPEAN JOURNAL OF HUMAN GENETICS, 1999, 7 (04) :407-408
[4]   Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study [J].
Dove-Edwin, I ;
Sasieni, P ;
Adams, J ;
Thomas, HJW .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 331 (7524) :1047-1049
[5]   Screening for the Lynch syndrome (Hereditary nonpolyposis colorectal cancer). [J].
Hampel, H ;
Frankel, WL ;
Martin, E ;
Arnold, M ;
Khanduja, K ;
Kuebler, P ;
Nakagawa, H ;
Sotamaa, K ;
Prior, TW ;
Westman, J ;
Panescu, J ;
Fix, D ;
Lockman, J ;
Comeras, I ;
de la Chapelle, A ;
Ellison, C ;
Melvin, S ;
Winston, J ;
Adeli, A ;
Burak, W ;
Chadwick, R ;
Elkhatib, I ;
Hemingway, T ;
Jamieson, K ;
Johnson, C ;
LaJeunesse, J ;
Liyanarachchi, S ;
Rangel, P ;
Soble, D ;
Walker, M ;
Wise, T ;
Zhang, Y ;
Schlanger, R ;
Aguilar, P ;
Hura, D ;
Keith, J ;
Kerner, B ;
Lavalle, G ;
Taylor, C ;
Vara, T ;
Zangmeister, J ;
DeVictor, S ;
Hines, L ;
Lindsey, M ;
Madhavan, J ;
Padmanabhan, A ;
Hamelberg, K ;
Niemann, T ;
Behrens, BC ;
Blair, SC .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (18) :1851-1860
[6]  
Hoang JM, 1997, CANCER RES, V57, P300
[7]   DOMINANT GENES FOR COLORECTAL-CANCER ARE NOT RARE [J].
HOULSTON, RS ;
COLLINS, A ;
SLACK, J ;
MORTON, NE .
ANNALS OF HUMAN GENETICS, 1992, 56 :99-103
[8]   Frequency of loss of hMLH1 expression in colorectal carcinoma increases with advancing age [J].
Kakar, S ;
Burgart, LJ ;
Thibodeau, SN ;
Rabe, KG ;
Petersen, GM ;
Goldberg, RM ;
Lindor, NM .
CANCER, 2003, 97 (06) :1421-1427
[9]   Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC [J].
Laken, SJ ;
Petersen, GM ;
Gruber, SB ;
Oddoux, C ;
Ostrer, H ;
Giardiello, FM ;
Hamilton, SR ;
Hampel, H ;
Markowitz, A ;
Klimstra, D ;
Jhanwar, S ;
Winawer, S ;
Offit, K ;
Luce, MC ;
Kinzler, KW ;
Vogelstein, B .
NATURE GENETICS, 1997, 17 (01) :79-83
[10]   Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency - Familial colorectal cancer type X [J].
Lindor, NM ;
Rabe, K ;
Petersen, GM ;
Haile, R ;
Casey, G ;
Baron, J ;
Gallinger, S ;
Bapat, B ;
Aronson, M ;
Hopper, J ;
Jass, J ;
LeMarchand, L ;
Grove, J ;
Potter, J ;
Newcomb, P ;
Terdiman, JP ;
Conrad, P ;
Moslein, G ;
Goldberg, R ;
Ziogas, A ;
Anton-Culver, H ;
de Andrade, M ;
Siegmund, K ;
Thibodeau, SN ;
Boardman, LA ;
Seminara, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (16) :1979-1985